AI image

Health · Nov 16, 2026 · Covered by 11 outlets in 10 countries

Six months of Bundibugyo Ebola: 11,000 cases, half of them fatal, and vaccines still in trials

DR Congo's Bundibugyo-strain outbreak has reached about 11,145 confirmed cases and 5,437 deaths, making it the second-largest Ebola outbreak on record, with active transmission in 51 of 67 affected health zones. Africa CDC and MSF say it is still not under control; only $1.3 billion of $2.9 billion pledged has been released, and the first strain-specific vaccine results are not expected before early 2027.

한국어로 보기 →

What happened

  • More than 11,000 cases and 5,400 deaths in six months (Politico.cd).
  • NOS calls it the second-largest Ebola outbreak ever and the deadliest in DRC's history.
  • MSF warns the outbreak is not under control amid 'dysfunctions' in the response (The National).
  • Nigeria completed monitoring of 62 contacts with no new infections (The Citizen).

The outbreak in numbers

11,145Confirmed casesUS CDC figures as of Nov 10; ECDC counts 11,114 in DRC as of Nov 11
5,437DeathsSecond-largest Ebola outbreak on record
48.7%Crude case fatality ratioWHO, data to Nov 3 (10,668 cases, 5,198 deaths)
51 / 67Health zones with active transmissionAcross eight provinces; Ituri worst hit
$1.3BReleased of $2.9B pledged by donorsAfrica CDC; Kaseya calls donor coordination 'a collective failure'
0Licensed vaccines or treatments for BundibugyoExisting Ebola vaccine Ervebo targets the Zaire strain

Six months on: still not under control

DR Congo declared its 17th Ebola outbreak on May 15, 2026, after Bundibugyo-specific tests confirmed the virus; standard tests had missed it because they detect only the Zaire species. The earliest known suspected case, in Ituri, fell ill on April 24. WHO declared a public health emergency of international concern in mid-May.

By November 10 the tally stood at about 11,145 confirmed cases and 5,437 deaths. WHO says transmission is active in 51 of 67 affected health zones across eight provinces, with Ituri the worst hit. Africa CDC's Jean Kaseya said this week that the outbreak 'is still serious, and is still not under control', while WHO's Tedros said transmission is slowing in several early epicentres.

Largest Ebola outbreaks by confirmed/reported cases
West Africa 2014–16 (Zaire)28,600 cases
DRC 2026 (Bundibugyo)11,145 cases
North Kivu 2018–20 (Zaire)3,470 cases
Uganda 2007–08 (Bundibugyo)131 cases
Isiro, DRC 2012 (Bundibugyo)62 cases

Before 2026, Bundibugyo virus had caused only two known outbreaks, with fatality of roughly 30–50%.

Source: WHO; US CDC via Contagion Live; peer-reviewed reviews of 2007 and 2012 outbreaks

How fast it grew: confirmed cases
Early Jul1,400 cases
Nov 310,668 cases
Nov 1011,145 cases

Early-July figure (more than 1,400 cases, 438 deaths) was reported when the treatment trial launched. ECDC logged 72 new confirmed cases and 46 deaths between its last two updates.

Source: AP (Jul 2); WHO DON (Nov 3 data); CDC via Contagion Live (Nov 10); ECDC (Nov 11)

Pledged vs released funding ($B)
Pledged2.9 $B
Released1.3 $B

Africa CDC separately said $700M of $962M disbursed was unaccounted for — a reporting failure, Kaseya said, too early to call embezzlement.

Source: Africa CDC via Al Jazeera (Nov 15); MyJoyOnline

Why it is so hard to stop

There is no licensed vaccine or treatment for Bundibugyo, which kills about half of those infected; Kaseya told RFI the absence of a vaccine explains the outbreak's scale. In the 2018–20 North Kivu outbreak, by contrast, a licensed Zaire-strain vaccine helped end transmission.

The response itself is faltering. MSF said its teams are 'often left speechless by the dysfunctions' — unpaid and untrained workers, ambulances without fuel, and surveillance teams that 'exist on paper but are nowhere to be seen on the ground' — calling the response too slow in North Kivu and Haut-Uélé 'dramatically overlooked'. In Butembo, response nurses, hygienists and supervisors announced an indefinite strike from November 12 over risk allowances.

Conflict compounds it. WHO's Tedros called for a ceasefire in eastern DRC as early as May, saying stopping transmission depends on humanitarian access, as fighting involving the M23 rebels and other armed groups continues; WHO has renewed calls to halt hostilities to protect the response.

How the outbreak ripples out

The vaccine and treatment race

The WHO-coordinated Tumaini trial vaccinated its first participant on October 26 with Merck's Ervebo, licensed for Zaire, to test whether it protects against Bundibugyo; a separate study, BRAVO, plans Ervebo shots for about 20,000 frontline workers. On November 4 WHO's advisers recommended adding two Bundibugyo-specific candidates — Oxford's ChAdOx1 BDBV and Moderna's mRNA-1469 — once national approvals are in place. Results are expected in early 2027.

Serum Institute of India has manufactured and stockpiled about 620,000 doses of the Oxford candidate. On treatment, a trial launched July 2 compares the Mapp Biopharmaceutical antibody MBP134 and remdesivir, alone or combined, in more than 1,000 patients, and a post-exposure trial of obeldesivir started in July. No efficacy results have been published.

Beyond Congo's borders

Uganda recorded 20 cases and two deaths. Kenya confirmed nine cases and two deaths, all linked to one imported case, with no new case since October 19. Nigeria confirmed an imported case in Abuja on October 20 in a woman arriving from Uganda; its 62 contacts reached the end of their 21-day monitoring around November 13 with no new infections, though the NCDC stresses only WHO can declare the country clear. France has also reported one case.

How the world's press frames it

CD Politico.cd / Radio Okapi

Local toll and frontline strain: 5,400 deaths in six months; Butembo civil society warns about the strike by response workers.

FR RFI

Africa CDC's Kaseya: 'the absence of a vaccine explains the scale of this epidemic.'

AE The National

MSF's warning that the outbreak is not under control amid 'dysfunctions'.

NL NOS

Explainer: second-largest Ebola outbreak ever, deadliest in DRC's history, and why it is so hard to fight.

KE KBC

WHO's call to halt hostilities to protect Ebola response gains.

PL Gazeta Wyborcza

Still out of control, more than 5,000 dead.

TZ The Citizen

Regional relief: Nigeria completes monitoring of 62 contacts with no new infections.

GB BBC News

Human story of a survivor who defied fear of treatment centres.

Past Ebola outbreaks

  1. 2007–08

    First recognised Bundibugyo outbreak, in Uganda's Bundibugyo district: about 131 cases and 42 deaths.

  2. 2012

    Bundibugyo outbreak in Isiro, DRC: 62 confirmed, probable and suspected cases, 34 deaths; declared over on Nov 26, 2012.

  3. 2014–16

    West Africa (Zaire strain): about 28,600 cases and 11,300 deaths — the largest Ebola epidemic.

  4. 2018–20

    North Kivu, DRC (Zaire strain): about 3,470 cases; WHO also called for a cessation of hostilities. A licensed vaccine helped end it.

  5. 2026

    DRC's 17th outbreak, the first large Bundibugyo epidemic: over 11,000 cases in six months, with no strain-specific vaccine.

What it means for Korea

  • The Korea Disease Control and Prevention Agency (KDCA) designated DR Congo, Uganda and South Sudan as priority quarantine areas after the PHEIC, requiring health declarations (Q-code) from arrivals; travellers with symptoms are told to call 1339.
  • Since September 7 a risk-based quarantine system has applied: arrivals from DR Congo face gate quarantine and up to 21 days of active monitoring.
  • Kenya was added as a priority area in October (health declarations from Oct 20), and on November 6 the KDCA widened its net after Nigeria's imported case; 13 countries are now on its quarantine-management list.
  • No case in Korea has been reported in the coverage reviewed.

Vaccine and treatment race

Likely to benefit

PriceMkt capP/EFwd P/E52-wk positionTarget (upside)Analysts
Moderna US

Its Bundibugyo candidate mRNA-1469 entered a phase 1 trial and was recommended by WHO advisers for the Tumaini trial in DRC; no revenue impact has been reported.

$223.3790.38Bn/an/a78%158.47 (-29.05%)Hold
Merck & Co. US

Its Zaire-strain vaccine Ervebo is being tested against Bundibugyo in the Tumaini trial and the ~20,000-worker BRAVO study.

$147.76364.26B149.4417.3886%161.53 (+9.32%)Buy
Gilead Sciences US

Remdesivir is one of two drugs in the WHO-backed treatment trial; obeldesivir is being tested as post-exposure prophylaxis.

$168.08208.48Bn/a20.1686%174.77 (+3.98%)Buy
Soligenix US

Shares nearly doubled pre-market on May 27 after it linked its ThermoVax platform to Bundibugyo — a move media noted rested on an early platform claim, not an order or approved product.

$0.32107.50Mn/an/a3%1.38 (+328.35%)n/a
GeoVax Labs US

The micro-cap vaccine developer's shares jumped almost 11% on May 20 as the outbreak spread; media describe such biodefense names as highly speculative.

$1.705646.04Kn/an/a0%Strong Buy

Under cost pressure

PriceMkt capP/EFwd P/E52-wk positionTarget (upside)Analysts

Prices at close Nov 13, 2026 (stockanalysis.com) · Company lists show exposure reported by analysts and media — not investment advice. Valuation metrics are third-party data as of the date shown.

Scenarios ahead

Base case

Slow decline in early epicentres but persistent spread in under-served zones (North Kivu, Haut-Uélé) into 2027, with funding releases and the Butembo pay dispute as near-term tests. Watch WHO's next Disease Outbreak News and whether Oxford and Moderna candidates win national approval to enter Tumaini.

Upside

Early-2027 trial data show Ervebo or a Bundibugyo-specific candidate protects, allowing targeted vaccination of contacts and frontline workers, while MBP134/remdesivir cut deaths — bending the curve.

Downside

Fighting cuts access, strikes spread and funds stay stuck; more exported cases follow along travel routes, as already seen in Kenya, Nigeria and France.

Sources (raw data, reporting, research)

  1. Contagion Live — Ebola outbreak reaches 11,145 cases, 5,437 deaths (2026-11)
  2. ECDC — Ebola disease outbreak caused by Bundibugyo virus (2026-11-12)
  3. WHO — Disease Outbreak News: Ebola disease caused by Bundibugyo virus, DRC, Kenya and Nigeria (DON625)
  4. Al Jazeera — Africa CDC says Ebola outbreak in DR Congo 'still not under control' (2026-11-15)
  5. The National — Ebola outbreak not under control amid 'dysfunctions' in response, MSF warns (2026-11-15)
  6. MyJoyOnline — Millions of Ebola dollars missing with staff unpaid while virus spreads, charity says (2026-11)
  7. RFI — Ebola: «L'absence de vaccin explique l'ampleur de cette épidémie», selon Jean Kaseya (2026-11-15)
  8. WHO — Two new candidate vaccines to join Ebola trial as treatment research advances (2026-11-04)
  9. MSF — Ebola: First person vaccinated in Tumaini clinical trial (2026-10)
  10. ClinicalTrials.gov — BRAVO: Ervebo vaccination in ~20,000 frontline workers (NCT07903350)
  11. University of Oxford — World's first Phase I Bundibugyo ebolavirus vaccine trial launched (2026-07-13)
  12. AP via ABC News — Researchers launch study on Ebola treatments as Congo outbreak worsens (2026-07-02)
  13. The Star (Reuters) — WHO urges ceasefire in Congo to contain Ebola as cases surge (2026-05-27)
  14. ACP — Ebola à Butembo: personnel impliqué dans la riposte annonce une grève dès jeudi (2026-11-10)
  15. Nairametrics — 34 Ebola contacts complete monitoring, 28 remain under surveillance: NCDC (2026-11-11)
  16. Genomic Epidemiology — 2026 Bundibugyo Ebola outbreak map and reported cases
  17. PMC review — Bundibugyo virus disease outbreaks 2007 and 2012
  18. 질병관리청 — 나이지리아 에볼라 해외유입 확인, 국내 유입 대비 검역망 넓힌다 (2026-11-06)
  19. TS2 — Soligenix stock nearly doubles before the bell as Ebola vaccine hopes put tiny biotech back in play (2026-05-27)
  20. Oninvest — The Ebola outbreak has sent shares of biotech GeoVax skyrocketing (2026-05)

Updated: 2026-11-16

How the world is covering it

Covered by 11 outlets in 10 countries: AE · CD · FR · GB · KE · NL · PL · SN · TZ · US

  1. PL Gazeta Wyborcza — Ebola w Demokratycznej Republice Konga wciąż poza kontrolą. Zmarło już ponad 5 tys. osób
  2. SN Senego — Ebola en RDC : Jean Kaseya attribue l’ampleur de l’épidémie à l’absence de vaccin
  3. FR RFI — Ebola: «L'absence de vaccin explique l'ampleur de cette épidémie», selon Jean Kaseya (Africa CDC)
  4. CD Politico.cd — RDC : plus de 5 400 morts d’Ebola en six mois, l’OMS alerte sur la poursuite de l’épidémie
  5. KE KBC — WHO calls for halt in DRC hostilities to protect Ebola response gains
  6. NL NOS — Einde aan dodelijke ebola-epidemie in Congo niet in zicht: waarom bestrijding lastig is
  7. CD Radio Okapi — La société civile de Butembo alerte sur les risques liés à la grève des prestataires de soins engagés dans la riposte contre Ebola
  8. TZ The Citizen — Nigeria completes Ebola monitoring of 62 contacts without detecting new infections
  9. AE The National — Ebola outbreak not under control amid 'dysfunctions' in response, MSF warns
  10. GB BBC News — My mother told me I would die if I sought treatment for Ebola - I am proof you can survive

What to watch

Watch vaccine trials for the Bundibugyo strain and whether ceasefires allow access to hot zones.

More stories today

Every morning · Free

The world in 5 minutes — GLOBE KOREA Briefing

The five stories that matter, the history behind them, what they mean for Korea and for markets — in one email.